Brazil released data Wednesday showing a 78 percent effectiveness rate for the China Kexin vaccine. The São Paulo state government has set a vaccination schedule, with the first vaccinations scheduled for Jan. 25.
The Financial Times reported today from Beijing that data released in Brazil on Wednesday showed that the Kexing vaccine is 78 percent effective.
A new coronavirus pneumonia (COVID-19, or 2019 coronavirus disease) vaccine developed by China’s Sinovac has been shown to be 78 percent effective in a phase III trial in Brazil.
This boosted China’s efforts to hone its medical technology abroad and catch up with Western vaccine makers, the report said.
The results, announced Wednesday by the Brazilian institution that conducted the trial, pave the way for the vaccine to be administered in Brazil and are good news for Beijing, which has made a major commitment to produce the vaccine and distribute it throughout the developing world, the report said.
Recent Comments